Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling Approach

Pharmacoepidemiology and Drug Safety(2025)10.1002/pds.70157Source: DataRank Database

Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling Approach is a research paper published in Pharmacoepidemiology and Drug Safety (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 0.00)OA: hybridTopics (48)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Deirdre Cronin‐Fenton ORCID,Per Damkier ORCID,Anders Kjærsgaard ORCID,Stephen Hamilton‐Dutoit ORCID,Bent Ejlertsen ORCID

Live enrichment

PubMed:40364655 PMC:PMC12076038 OpenAlex:https://openalex.org/W4410377717

NCI NIH HHS

Grant: R00 CA277580

National Cancer Institute

Lundbeck Foundation

Mary Kay Ash Foundation

Susan G. Komen for the Cure

US National Institute for General Medical Sciences

Danmarks Frie Forskningsfond

US National Institute for General Medical Sciences

Mary Kay Ash Foundation

Lundbeck Foundation

Susan G. Komen for the Cure

FWCI

0.00

Citation Percentile

0.1%

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.70157

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pds.70157

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.70157

journalhttps://doi.org/10.1002/pds.70157

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40364655

Fields of Study

Pharmacogenetics and Drug MetabolismEstrogen and related hormone effectsInflammatory mediators and NSAID effectsHumansFemaleTamoxifenBayes TheoremBreast NeoplasmsPremenopauseAdultDrug InteractionsAntineoplastic Agents, HormonalMiddle AgedCohort StudiesTreatment OutcomeNeoplasm Recurrence, Local

MeSH Terms

AdultBayes TheoremBreast NeoplasmsDrug InteractionsFemaleHumansMiddle AgedNeoplasm Recurrence, LocalTamoxifenCohort StudiesTreatment OutcomePremenopauseAntineoplastic Agents, Hormonal

Keywords

MedicineTamoxifenBreast cancerHazard ratioCYP2C19Internal medicineOncologyCYP2D6ConcomitantProportional hazards modelCohortConfidence intervalCancerGynecologyCytochrome P450Breast neoplasmsDrug interactionsPharmacoepidemiologyJoint Modeling

Sustainable Development Goals

SDG 0: Good health and well-being